Mount Yale Investment Advisors’s Ambev ABEV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$49.5K Sell
15,657
-1,109
-7% -$3.47K ﹤0.01% 1186
2026
Q1
$49.2K Buy
16,766
+1,503
+10% +$4.29K ﹤0.01% 1089
2025
Q4
$39K Buy
15,263
+612
+4% +$1.46K ﹤0.01% 717
2025
Q3
$33K Buy
+14,651
New +$33.5K ﹤0.01% 668
2018
Q4
– Sell
-4,075
Closed -$18K – 309
2018
Q3
$18K Hold
4,075
– – ﹤0.01% 797
2018
Q2
$19K Buy
+4,075
New +$23.9K ﹤0.01% 800

Other funds holding ABEV

Mount Yale Investment Advisors's ABEV Position: Q2 2026 in Review

Mount Yale Investment Advisors reduced its Ambev (ABEV) stake by 6.6% in Q2 2026, selling an estimated $3.47K and leaving 15,657 shares worth $49.5K. The position accounts for ﹤0.01% of the portfolio, ranked #1186.

Mount Yale Investment Advisors first reported a position in ABEV in Q2 2018 and has held it in 6 quarters since. 404 funds tracked by Wall St. Rank hold ABEV as of Q2 2026.

  • Mount Yale Investment Advisors held 15,657 shares of Ambev worth $49.5K as of Q2 2026.
  • Mount Yale Investment Advisors sold 1,109 Ambev shares in Q2 2026, an estimated $3.47K.
  • Ambev made up ﹤0.01% of Mount Yale Investment Advisors's portfolio in Q2 2026, its #1186 holding.
  • Mount Yale Investment Advisors first reported a position in Ambev in Q2 2018 and has held it in 6 quarters since.
  • 404 funds tracked by Wall St. Rank held Ambev as of Q2 2026.

Based on Mount Yale Investment Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.